Skip to main content

Table 3 Pre-test adjusted comparison of post-test scores between the groups

From: An old approach to a novel problem: effect of combined balance therapy on virtual reality induced motion sickness: a randomized, placebo controlled, double-blinded study

 

Intervention (n = 60)

Placebo Control (n = 61)

   

X ± SD

X ± SD

F

p

ηp2

VRSQ Total

46.23 ± 16.79

74.24 ± 13.69

102.446

< 0,001

0.465

VRSQ Oculomotor

21.15 ± 7.98

33.82 ± 6.17

97.060

< 0,001

0.451

VRSQ Discomfort

25.08 ± 8.93

41.15 ± 8.17

105.910

< 0,001

0.473

Tolerance (minute)

12.75 ± 2.64

8.73 ± 2.85

63.916

< 0,001

0.351

VAS (mm)

45.86 ± 19.77

28.58 ± 16.30

26.671

< 0,001

0.184

OSI

0.49 ± 0.26

0.35 ± 0.28

6.074

0.015

0.049

FBT

0.64 ± 0.28

0.44 ± 0.32

17.429

< 0,001

0.129

  1. VRSQ Virtual reality sickness questionnaire: VAS Visual analogue scale: OSI Overall stability index: FBT Flamingo balance test: ηp2 Partial ETA square: F ANCOVA test: CI Confidence Interval p < 0.05
Back to article page

BMC Medical Education

ISSN: 1472-6920

Contact us